Clincosm LogoSign in Get a demo

Recurrent Grade 1 Follicular Lymphoma

Showing NaN - NaN of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Grade 3a Follicular Lymphoma, Recurrent Follicular Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Houston (other,

Completed
  • Grade 3a Follicular Lymphoma
  • +9 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 31, 2023

Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Angioimmunoblastic T-Cell Lymphoma, Recurrent Grade 1

Active, not recruiting
  • Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
  • +18 more
  • Anti-ICOS Monoclonal Antibody MEDI-570
  • +2 more
  • Duarte, California
  • +22 more
Jan 18, 2023

Recurrent DLBCL, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma Trial in Houston (other, drug,

Recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +3 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 26, 2022

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +35 more
  • Akt inhibitor MK2206
  • laboratory biomarker analysis
  • Houston, Texas
    M D Anderson Cancer Center
Oct 14, 2020

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +45 more
  • anti-endosialin/TEM1 monoclonal antibody MORAb-004
  • +2 more
  • Birmingham, Alabama
  • +19 more
Jan 7, 2016

MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma Trial in Houston (recombinant

Completed
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • +16 more
  • recombinant interleukin-12
  • laboratory biomarker analysis
  • Houston, Texas
    M D Anderson Cancer Center
Apr 14, 2015

Cutaneous B-cell Non-Hodgkin Lymphoma, MALT, Intraocular Lymphoma Trial in Houston (oblimersen sodium, rituximab, laboratory

Completed
Has Results
  • Cutaneous B-cell Non-Hodgkin Lymphoma
  • +20 more
  • oblimersen sodium
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
May 13, 2014

Accelerated Phase Chronic Myelogenous Leukemia, Acute Leukemias of Ambiguous Lineage, Acute Myeloid Leukemia/Transient

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +50 more
  • Akt inhibitor MK2206
  • +2 more
  • Birmingham, Alabama
  • +24 more
Apr 28, 2014

Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma

Completed
  • Adult Grade III Lymphomatoid Granulomatosis
  • +61 more
  • bevacizumab
  • cediranib maleate
  • Houston, Texas
    M D Anderson Cancer Center
Feb 14, 2014

Angioimmunoblastic T-cell Lymphoma, MALT, Nodal Marginal Zone B-cell Lymphoma Trial in Houston (nelarabine)

Terminated
  • Angioimmunoblastic T-cell Lymphoma
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 22, 2013

Angioimmunoblastic T-cell Lymphoma, MALT, Nodal Marginal Zone B-cell Lymphoma Trial in Houston (oxaliplatin)

Completed
  • Angioimmunoblastic T-cell Lymphoma
  • +16 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 22, 2013